Agenus Inc - Company & Market Research Reports

Agenus is an immuno-oncology company that focuses on the discovery and development of treatments that engage the body's immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates. It is also developing Prophage, a heat shock protein-based autologous vaccine. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.


Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H1 2018

  • Report
  • 63 Pages
From
Competitor Analysis: Cancer Vaccines - Product Thumbnail Image

Competitor Analysis: Cancer Vaccines

  • Report
  • 179 Pages
From
Glucocorticoid Induced Tumor Necrosis Factor Receptor (Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H1 2016 - Product Thumbnail Image

Glucocorticoid Induced Tumor Necrosis Factor Receptor (Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H1 2016

  • Report
  • 57 Pages
From
Global Herpes Treatment Market 2017-2021 - Product Thumbnail Image

Global Herpes Treatment Market 2017-2021

  • Report
  • 82 Pages
From
Herpes Simplex Virus Treatment - Global Strategic Business Report - Product Thumbnail Image

Herpes Simplex Virus Treatment - Global Strategic Business Report

  • Report
  • 300 Pages
From
Herpes Simplex Infections - Pipeline Review, H1 2015 - Product Thumbnail Image

Herpes Simplex Infections - Pipeline Review, H1 2015

  • Report
  • 188 Pages
From
Intracellular Targets Made Druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: An Industry Analysis of Technologies, Stakeholders, Deals & Trends - Product Thumbnail Image

Intracellular Targets Made Druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: An Industry Analysis of Technologies, Stakeholders, Deals & Trends

  • Report
  • 252 Pages
From
Programmed Cell Death Protein 1 (CD279 or Systemic Lupus Erythematosus Susceptibility 2 or PD1) - Pipeline Review, H1 2016 - Product Thumbnail Image

Programmed Cell Death Protein 1 (CD279 or Systemic Lupus Erythematosus Susceptibility 2 or PD1) - Pipeline Review, H1 2016

  • Report
  • 181 Pages
From
Global - Cancer Vaccines Market and Pipeline Vaccines Analysis to 2020 - Product Thumbnail Image

Global - Cancer Vaccines Market and Pipeline Vaccines Analysis to 2020

  • Report
  • 213 Pages
From
Immune Checkpoint Inhibitors: Clinical Trial Tracker - Product Thumbnail Image

Immune Checkpoint Inhibitors: Clinical Trial Tracker

  • Clinical Trials
From
Global Vaccine Adjuvants Market Research Report, Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023 - Product Thumbnail Image

Global Vaccine Adjuvants Market Research Report, Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • Report
  • 190 Pages
From
Vaccine Adjuvants Market Size And Forecast By Type, By Application, And Trend Analysis, 2014 - 2025 - Product Thumbnail Image

Vaccine Adjuvants Market Size And Forecast By Type, By Application, And Trend Analysis, 2014 - 2025

  • Report
  • 90 Pages
From
Vaccine Adjuvants Market by Product Type, Route of Administration, Disease Type, Application & Application Category - Forecasts to 2021 - Product Thumbnail Image

Vaccine Adjuvants Market by Product Type, Route of Administration, Disease Type, Application & Application Category - Forecasts to 2021

  • Report
  • 159 Pages
From
Therapeutic Vaccine Market: By Vaccine Type; By Technology & By Region - Forecast 2016-2021 - Product Thumbnail Image

Therapeutic Vaccine Market: By Vaccine Type; By Technology & By Region - Forecast 2016-2021

  • Report
  • 152 Pages
From
Therapeutic Vaccines Market: 2016 - 2022 - Product Thumbnail Image

Therapeutic Vaccines Market: 2016 - 2022

  • Report
  • 110 Pages
From
Global Therapeutic vaccine Market - Segmented by Type, and Geography - Growth, Trends and Forecasts (2018 - 2023) - Product Thumbnail Image

Global Therapeutic vaccine Market - Segmented by Type, and Geography - Growth, Trends and Forecasts (2018 - 2023)

  • Report
  • 115 Pages
From
Global Therapeutic Vaccines Market - Growth, Trends & Forecasts 2017 - 2022 - Product Thumbnail Image

Global Therapeutic Vaccines Market - Growth, Trends & Forecasts 2017 - 2022

  • Report
  • 211 Pages
From
Opportunity in the Global Vaccine Adjuvants Market - 2018 - Product Thumbnail Image

Opportunity in the Global Vaccine Adjuvants Market - 2018

  • Report
  • 93 Pages
From
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018 - Product Thumbnail Image

Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018

  • Report
  • 1000 Pages
From
Global Immune Check Point Inhibitors Market & Clinical Pipeline Insight 2022 - Product Thumbnail Image

Global Immune Check Point Inhibitors Market & Clinical Pipeline Insight 2022

  • Drug Pipelines
  • 222 Pages
From
Loading Indicator
adroll